<div id="readability-page-1"><div> (RTTNews) - Biotech companies are seeing significant pre-market activity this Friday, hinting at possible breakout opportunities. By evaluating sentiment and momentum before the bell, premarket analysis becomes a foundational step in any trader's routine. In the Green - Premarket Gainers On Friday, the following stocks were trading significantly higher in the premarket session. 1. Replimune Group, Inc. (REPL) - up 69% at $7.92 2. aTyr Pharma, Inc. (ATYR) - up 15% at $0.56 3. Basel Medical Group Ltd. (BMGL) - up 10% at $0.64 4. Artiva Biotherapeutics, Inc. (ARTV) - up 10% at $8.34 5. Moolec Science SA. (MLEC) - up 10% at $2.42 6. Citius Oncology, Inc. (CTOR) - up 8% at $0.87 7. Galectin Therapeutics Inc. (GALT) - up 6% at $2.73 8. KALA BIO, Inc. (KALA) - up 6% at $2.50 9. Polaryx Therapeutics, Inc. (PLYX) - up 5% at $3.20 10. Keros Therapeutics, Inc. (KROS) - up 5% at $12 In the Red - Premarket Losers The following stocks were trading lower in the premarket session on Friday. 1. Rocket One Inc. (RKTO) - down 16% at $1.43 2. SciSparc Ltd. (SPRC) -down 13% at $9.15 3. Aethlon Medical, Inc. (AEMD) -down 11% at $2.60 4. Sunshine Biopharma, Inc. (SBFM) -down 8% at $0.29 5. BioNexus Gene Lab Corp. (BGLC) - down 8% at $2.21 6. AIM ImmunoTech Inc. (AIM) -down 8% at $0.41 7. Nuwellis, Inc. (NUWE) -down 7% at $0.78 8. Jupiter Neurosciences, Inc. (JUNS) -down 7% at $0.27 9. Indaptus Therapeutics, Inc. (INDP) - down 7% at $1.35 10. BioRestorative Therapies, Inc. (BRTX) - down 6% at $0.45 For More Such Biotech Stock News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. </div></div>

SPRC

RKTO

ATYR

Biotech stocks showed significant pre-market activity on Friday. Replimune Group (REPL) led gainers, surging 69% to $7.92, followed by aTyr Pharma (ATYR) up 15%. Other notable gainers included Basel Medical Group and Artiva Biotherapeutics. On the downside, Rocket One Inc. (RKTO) fell 16%, while SciSparc Ltd. (SPRC) dropped 13%. The session highlighted potential breakout opportunities amid shifting sentiment.

nasdaq

SciSparc

Rocket One

ATYR Pharma

Artiva Biotherapeutics

Basel Medical

Replimune

Health Care Select Sector SPDR

Proshares UltraShort Nasdaq Biotech

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

iShares US Healthcare Providers

Ark Genomic Revolution ETF

VanEck Biotech ETF

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

SPDR S&P Health

Invesco Biotechnology & Genome ETF

VG Health

Direxion S&P Biotech Bull 3X

Direxion S&P Biotech Bear 3X

Proshares Ultra Nasdaq Biotech

iShares US Pharma

SPDR S&P Biotech

Moolec Science SA

Citius Oncology

Galectin Therap

KALA BIO

Polaryx Therapeutics

Keros Therapeutics

Aethlon Medical

Sunshine Biopharma

BioNexus Gene Lab

AIM ImmunoTech

Nuwellis

Jupiter Neurosciences

Indaptus Therapeutics

Biorestorative Therapies

Nasdaq

MOOLEC SCIENCE SA C/WTS 30/01/2028(TO PUR COM)

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

AIM IMMUNOTECH INC

AIM ImmunoTech Inc.

Pre-Market Movers: REPL, BMGL, SPRC Chart The Course